$DLB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Dolby Laboratories, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Dolby Laboratories, Inc.. Get notifications about new insider transactions in Dolby Laboratories, Inc. for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 69 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 21 2019 | DLB | Dolby Laboratories ... | Dolby Dagmar | 10% Owner | Option Exercise | C | 0.00 | 19,885 | 0 | 6,828,077 | |
| Feb 21 2019 | DLB | Dolby Laboratories ... | Dolby Dagmar | 10% Owner | Option Exercise | C | 0.00 | 50,000 | 0 | 6,847,962 | |
| Feb 21 2019 | DLB | Dolby Laboratories ... | Dolby Dagmar | 10% Owner | Sell | S | 65.06 | 19,885 | 1,293,806 | 0 | 19.9 K to 0 (-100.00 %) |
| Feb 21 2019 | DLB | Dolby Laboratories ... | Dolby Dagmar | 10% Owner | Buy | C | 0.00 | 19,885 | 0 | 19,885 | 0 to 19.9 K |
| Feb 21 2019 | DLB | Dolby Laboratories ... | Dolby Dagmar | 10% Owner | Sell | S | 65.42 | 50,000 | 3,270,950 | 0 | 50 K to 0 (-100.00 %) |
| Feb 21 2019 | DLB | Dolby Laboratories ... | Dolby Dagmar | 10% Owner | Buy | C | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
| Feb 20 2019 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Option Exercise | M | 30.49 | 25,000 | 762,250 | 206,968 | |
| Feb 20 2019 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 65.00 | 25,000 | 1,625,000 | 32,895 | 57.9 K to 32.9 K (-43.18 %) |
| Feb 20 2019 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Buy | M | 30.49 | 25,000 | 762,250 | 57,895 | 32.9 K to 57.9 K (+76.00 %) |
| Feb 20 2019 | DLB | Dolby Laboratories ... | Dolby Dagmar | 10% Owner | Option Exercise | C | 0.00 | 50,000 | 0 | 6,897,962 | |
| Feb 20 2019 | DLB | Dolby Laboratories ... | Dolby Dagmar | 10% Owner | Option Exercise | C | 0.00 | 401 | 0 | 6,947,962 | |
| Feb 20 2019 | DLB | Dolby Laboratories ... | Dolby Dagmar | 10% Owner | Sell | S | 65.41 | 50,000 | 3,270,620 | 0 | 50 K to 0 (-100.00 %) |
| Feb 20 2019 | DLB | Dolby Laboratories ... | Dolby Dagmar | 10% Owner | Buy | C | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
| Feb 20 2019 | DLB | Dolby Laboratories ... | Dolby Dagmar | 10% Owner | Sell | S | 65.00 | 401 | 26,067 | 0 | 401 to 0 (-100.00 %) |
| Feb 20 2019 | DLB | Dolby Laboratories ... | Dolby Dagmar | 10% Owner | Buy | C | 0.00 | 401 | 0 | 401 | 0 to 401 |
| Feb 13 2019 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Option Exercise | M | 30.49 | 2,432 | 74,152 | 231,968 | |
| Feb 13 2019 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Option Exercise | M | 28.24 | 948 | 26,772 | 0 | |
| Feb 13 2019 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 62.97 | 2,432 | 153,153 | 32,895 | 35.3 K to 32.9 K (-6.88 %) |
| Feb 13 2019 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Buy | M | 30.49 | 2,432 | 74,152 | 35,327 | 32.9 K to 35.3 K (+7.39 %) |
| Feb 13 2019 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 62.84 | 948 | 59,570 | 32,895 | 33.8 K to 32.9 K (-2.80 %) |
| Feb 13 2019 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Buy | M | 28.24 | 948 | 26,772 | 33,843 | 32.9 K to 33.8 K (+2.88 %) |
| Feb 12 2019 | DLB | Dolby Laboratories ... | CHEW LEWIS | EVP & Chief Financi ... | Option Exercise | M | 37.96 | 35,000 | 1,328,600 | 37,185 | |
| Feb 12 2019 | DLB | Dolby Laboratories ... | CHEW LEWIS | EVP & Chief Financi ... | Sell | S | 63.28 | 35,000 | 2,214,643 | 91,946 | 126.9 K to 91.9 K (-27.57 %) |
| Feb 12 2019 | DLB | Dolby Laboratories ... | CHEW LEWIS | EVP & Chief Financi ... | Buy | M | 37.96 | 35,000 | 1,328,600 | 126,946 | 91.9 K to 126.9 K (+38.07 %) |
| Feb 11 2019 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Option Exercise | M | 28.24 | 50,000 | 1,412,000 | 948 | |
| Feb 11 2019 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Option Exercise | M | 28.24 | 44,328 | 1,251,823 | 50,948 | |
| Feb 11 2019 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 63.81 | 4,428 | 282,552 | 32,895 | 37.3 K to 32.9 K (-11.86 %) |
| Feb 11 2019 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 63.31 | 45,572 | 2,885,122 | 37,323 | 82.9 K to 37.3 K (-54.98 %) |
| Feb 11 2019 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Buy | M | 28.24 | 50,000 | 1,412,000 | 82,895 | 32.9 K to 82.9 K (+152.00 %) |
| Feb 11 2019 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 64.68 | 886 | 57,306 | 32,895 | 33.8 K to 32.9 K (-2.62 %) |
| Feb 11 2019 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 64.02 | 43,442 | 2,781,013 | 33,781 | 77.2 K to 33.8 K (-56.26 %) |
| Feb 11 2019 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Buy | M | 28.24 | 44,328 | 1,251,823 | 77,223 | 32.9 K to 77.2 K (+134.76 %) |
| Feb 11 2019 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 64.19 | 5,672 | 364,070 | 32,895 | 38.6 K to 32.9 K (-14.71 %) |
| Feb 11 2019 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Option Exercise | M | 28.24 | 50,000 | 1,412,000 | 948 | |
| Feb 11 2019 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Option Exercise | M | 28.24 | 44,328 | 1,251,823 | 50,948 | |
| Feb 11 2019 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 63.81 | 4,428 | 282,552 | 32,895 | 37.3 K to 32.9 K (-11.86 %) |
| Feb 11 2019 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 63.31 | 45,572 | 2,885,122 | 37,323 | 82.9 K to 37.3 K (-54.98 %) |
| Feb 11 2019 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Buy | M | 28.24 | 50,000 | 1,412,000 | 82,895 | 32.9 K to 82.9 K (+152.00 %) |
| Feb 11 2019 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 64.68 | 886 | 57,306 | 32,895 | 33.8 K to 32.9 K (-2.62 %) |
| Feb 11 2019 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 64.02 | 43,442 | 2,781,013 | 33,781 | 77.2 K to 33.8 K (-56.26 %) |
| Feb 11 2019 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Buy | M | 28.24 | 44,328 | 1,251,823 | 77,223 | 32.9 K to 77.2 K (+134.76 %) |
| Feb 11 2019 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 64.19 | 5,672 | 364,070 | 32,895 | 38.6 K to 32.9 K (-14.71 %) |
| Feb 07 2019 | DLB | Dolby Laboratories ... | Dolby Dagmar | 10% Owner | Option Exercise | C | 0.00 | 50,000 | 0 | 6,948,363 | |
| Feb 07 2019 | DLB | Dolby Laboratories ... | Dolby Dagmar | 10% Owner | Sell | S | 65.25 | 50,000 | 3,262,410 | 0 | 50 K to 0 (-100.00 %) |
| Feb 07 2019 | DLB | Dolby Laboratories ... | Dolby Dagmar | 10% Owner | Buy | C | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
| Feb 06 2019 | DLB | Dolby Laboratories ... | TEVANIAN AVADIS | Director | Sell | S | 65.00 | 1,960 | 127,400 | 46,750 | 48.7 K to 46.8 K (-4.02 %) |
| Feb 06 2019 | DLB | Dolby Laboratories ... | TEVANIAN AVADIS | Director | Grant | A | 0.00 | 3,996 | 0 | 3,996 | 0 to 4 K |
| Feb 06 2019 | DLB | Dolby Laboratories ... | SIBONI ROGER S | Director | Grant | A | 0.00 | 3,996 | 0 | 28,483 | 24.5 K to 28.5 K (+16.32 %) |
| Feb 06 2019 | DLB | Dolby Laboratories ... | Segars Simon | Director | Grant | A | 0.00 | 3,996 | 0 | 28,483 | 24.5 K to 28.5 K (+16.32 %) |
| Feb 06 2019 | DLB | Dolby Laboratories ... | JASPER N WILLIAM JR | Director | Sell | S | 65.00 | 3,920 | 254,800 | 7,000 | 10.9 K to 7 K (-35.90 %) |
| Feb 06 2019 | DLB | Dolby Laboratories ... | JASPER N WILLIAM JR | Director | Grant | A | 0.00 | 3,996 | 0 | 3,996 | 0 to 4 K |
| Feb 06 2019 | DLB | Dolby Laboratories ... | GOTCHER PETER C | Director | Sell | S | 65.00 | 3,920 | 254,800 | 42,645 | 46.6 K to 42.6 K (-8.42 %) |
| Feb 06 2019 | DLB | Dolby Laboratories ... | GOTCHER PETER C | Director | Grant | A | 0.00 | 3,996 | 0 | 46,565 | 42.6 K to 46.6 K (+9.39 %) |
| Feb 06 2019 | DLB | Dolby Laboratories ... | Dolby David | Director | Grant | A | 0.00 | 3,996 | 0 | 69,066 | 65.1 K to 69.1 K (+6.14 %) |
| Feb 06 2019 | DLB | Dolby Laboratories ... | Chau Micheline | Director | Grant | A | 0.00 | 3,996 | 0 | 54,515 | 50.5 K to 54.5 K (+7.91 %) |
| Feb 06 2019 | DLB | Dolby Laboratories ... | Dolby Dagmar | 10% Owner | Option Exercise | C | 0.00 | 50,000 | 0 | 6,998,363 | |
| Feb 06 2019 | DLB | Dolby Laboratories ... | Dolby Dagmar | 10% Owner | Option Exercise | C | 0.00 | 2,254 | 0 | 7,048,363 | |
| Feb 06 2019 | DLB | Dolby Laboratories ... | Dolby Dagmar | 10% Owner | Sell | S | 65.40 | 50,000 | 3,270,135 | 0 | 50 K to 0 (-100.00 %) |
| Feb 06 2019 | DLB | Dolby Laboratories ... | Dolby Dagmar | 10% Owner | Buy | C | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
| Feb 06 2019 | DLB | Dolby Laboratories ... | Dolby Dagmar | 10% Owner | Sell | S | 65.01 | 2,254 | 146,521 | 0 | 2.3 K to 0 (-100.00 %) |
| Feb 06 2019 | DLB | Dolby Laboratories ... | Dolby Dagmar | 10% Owner | Buy | C | 0.00 | 2,254 | 0 | 2,254 | 0 to 2.3 K |
| Dec 19 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Option Exercise | A | 64.60 | 164,000 | 10,594,400 | 164,000 | |
| Dec 19 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Option Exercise | A | 64.60 | 164,000 | 10,594,400 | 164,000 | |
| Dec 19 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Option Exercise | A | 64.60 | 82,000 | 5,297,200 | 82,000 | |
| Dec 19 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Option Exercise | A | 64.60 | 82,000 | 5,297,200 | 82,000 | |
| Dec 19 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 65.16 | 600 | 39,096 | 38,567 | 39.2 K to 38.6 K (-1.53 %) |
| Dec 19 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 65.16 | 600 | 39,096 | 38,567 | 39.2 K to 38.6 K (-1.53 %) |
| Dec 19 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 64.56 | 17,001 | 1,097,578 | 39,167 | 56.2 K to 39.2 K (-30.27 %) |
| Dec 19 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 64.56 | 17,001 | 1,097,578 | 39,167 | 56.2 K to 39.2 K (-30.27 %) |
| Dec 19 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Grant | A | 0.00 | 41,000 | 0 | 109,664 | 68.7 K to 109.7 K (+59.71 %) |
| Dec 19 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Grant | A | 0.00 | 41,000 | 0 | 109,664 | 68.7 K to 109.7 K (+59.71 %) |
| Dec 19 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Payment of Exercise | F | 66.17 | 22,891 | 1,514,697 | 68,664 | 91.6 K to 68.7 K (-25.00 %) |
| Dec 19 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Payment of Exercise | F | 66.17 | 22,891 | 1,514,697 | 68,664 | 91.6 K to 68.7 K (-25.00 %) |
| Dec 19 2018 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Option Exercise | A | 64.60 | 52,000 | 3,359,200 | 52,000 | |
| Dec 19 2018 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Option Exercise | A | 64.60 | 52,000 | 3,359,200 | 52,000 | |
| Dec 19 2018 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Option Exercise | A | 64.60 | 26,000 | 1,679,600 | 26,000 | |
| Dec 19 2018 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Option Exercise | A | 64.60 | 26,000 | 1,679,600 | 26,000 | |
| Dec 19 2018 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Sell | S | 65.15 | 400 | 26,062 | 49,943 | 50.3 K to 49.9 K (-0.79 %) |
| Dec 19 2018 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Sell | S | 65.15 | 400 | 26,062 | 49,943 | 50.3 K to 49.9 K (-0.79 %) |
| Dec 19 2018 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Sell | S | 64.49 | 4,326 | 279,001 | 50,343 | 54.7 K to 50.3 K (-7.91 %) |
| Dec 19 2018 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Sell | S | 64.49 | 4,326 | 279,001 | 50,343 | 54.7 K to 50.3 K (-7.91 %) |
| Dec 19 2018 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Grant | A | 0.00 | 13,000 | 0 | 54,669 | 41.7 K to 54.7 K (+31.20 %) |
| Dec 19 2018 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Grant | A | 0.00 | 13,000 | 0 | 54,669 | 41.7 K to 54.7 K (+31.20 %) |
| Dec 19 2018 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Payment of Exercise | F | 66.17 | 6,387 | 422,628 | 41,669 | 48.1 K to 41.7 K (-13.29 %) |
| Dec 19 2018 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Payment of Exercise | F | 66.17 | 6,387 | 422,628 | 41,669 | 48.1 K to 41.7 K (-13.29 %) |
| Dec 19 2018 | DLB | Dolby Laboratories ... | Pendleton Todd | SVP, Chief Marketin ... | Option Exercise | A | 64.60 | 36,000 | 2,325,600 | 36,000 | |
| Dec 19 2018 | DLB | Dolby Laboratories ... | Pendleton Todd | SVP, Chief Marketin ... | Option Exercise | A | 64.60 | 36,000 | 2,325,600 | 36,000 | |
| Dec 19 2018 | DLB | Dolby Laboratories ... | Pendleton Todd | SVP, Chief Marketin ... | Option Exercise | A | 64.60 | 18,000 | 1,162,800 | 18,000 | |
| Dec 19 2018 | DLB | Dolby Laboratories ... | Pendleton Todd | SVP, Chief Marketin ... | Option Exercise | A | 64.60 | 18,000 | 1,162,800 | 18,000 | |
| Dec 19 2018 | DLB | Dolby Laboratories ... | Pendleton Todd | SVP, Chief Marketin ... | Grant | A | 0.00 | 9,000 | 0 | 26,500 | 17.5 K to 26.5 K (+51.43 %) |
| Dec 19 2018 | DLB | Dolby Laboratories ... | Pendleton Todd | SVP, Chief Marketin ... | Grant | A | 0.00 | 9,000 | 0 | 26,500 | 17.5 K to 26.5 K (+51.43 %) |
| Dec 19 2018 | DLB | Dolby Laboratories ... | Forshay Steven E | SVP, Advanced Techn ... | Option Exercise | A | 0.00 | 27,000 | 0 | 27,000 | |
| Dec 19 2018 | DLB | Dolby Laboratories ... | Forshay Steven E | SVP, Advanced Techn ... | Option Exercise | A | 0.00 | 27,000 | 0 | 27,000 | |
| Dec 19 2018 | DLB | Dolby Laboratories ... | Forshay Steven E | SVP, Advanced Techn ... | Grant | A | 0.00 | 4,500 | 0 | 66,625 | 62.1 K to 66.6 K (+7.24 %) |
| Dec 19 2018 | DLB | Dolby Laboratories ... | Forshay Steven E | SVP, Advanced Techn ... | Grant | A | 0.00 | 4,500 | 0 | 66,625 | 62.1 K to 66.6 K (+7.24 %) |
| Dec 19 2018 | DLB | Dolby Laboratories ... | Forshay Steven E | SVP, Advanced Techn ... | Payment of Exercise | F | 66.17 | 3,285 | 217,368 | 62,125 | 65.4 K to 62.1 K (-5.02 %) |
| Dec 19 2018 | DLB | Dolby Laboratories ... | Forshay Steven E | SVP, Advanced Techn ... | Payment of Exercise | F | 66.17 | 3,285 | 217,368 | 62,125 | 65.4 K to 62.1 K (-5.02 %) |
| Dec 19 2018 | DLB | Dolby Laboratories ... | CHEW LEWIS | EVP & Chief Financi ... | Option Exercise | A | 64.60 | 52,000 | 3,359,200 | 52,000 | |
| Dec 19 2018 | DLB | Dolby Laboratories ... | CHEW LEWIS | EVP & Chief Financi ... | Option Exercise | A | 64.60 | 52,000 | 3,359,200 | 52,000 | |
| Dec 19 2018 | DLB | Dolby Laboratories ... | CHEW LEWIS | EVP & Chief Financi ... | Option Exercise | A | 64.60 | 26,000 | 1,679,600 | 26,000 | |
| Dec 19 2018 | DLB | Dolby Laboratories ... | CHEW LEWIS | EVP & Chief Financi ... | Option Exercise | A | 64.60 | 26,000 | 1,679,600 | 26,000 | |
| Dec 19 2018 | DLB | Dolby Laboratories ... | CHEW LEWIS | EVP & Chief Financi ... | Grant | A | 0.00 | 13,000 | 0 | 91,946 | 78.9 K to 91.9 K (+16.47 %) |
| Dec 19 2018 | DLB | Dolby Laboratories ... | CHEW LEWIS | EVP & Chief Financi ... | Grant | A | 0.00 | 13,000 | 0 | 91,946 | 78.9 K to 91.9 K (+16.47 %) |
| Dec 19 2018 | DLB | Dolby Laboratories ... | CHEW LEWIS | EVP & Chief Financi ... | Payment of Exercise | F | 66.17 | 7,424 | 491,246 | 78,946 | 86.4 K to 78.9 K (-8.60 %) |
| Dec 19 2018 | DLB | Dolby Laboratories ... | CHEW LEWIS | EVP & Chief Financi ... | Payment of Exercise | F | 66.17 | 7,424 | 491,246 | 78,946 | 86.4 K to 78.9 K (-8.60 %) |
| Dec 19 2018 | DLB | Dolby Laboratories ... | Baker Giles | SVP, Consumer Enter ... | Option Exercise | A | 64.60 | 50,000 | 3,230,000 | 50,000 | |
| Dec 19 2018 | DLB | Dolby Laboratories ... | Baker Giles | SVP, Consumer Enter ... | Option Exercise | A | 64.60 | 25,000 | 1,615,000 | 25,000 | |
| Dec 19 2018 | DLB | Dolby Laboratories ... | Baker Giles | SVP, Consumer Enter ... | Option Exercise | A | 64.60 | 50,000 | 3,230,000 | 50,000 | |
| Dec 19 2018 | DLB | Dolby Laboratories ... | Baker Giles | SVP, Consumer Enter ... | Sell | S | 65.23 | 100 | 6,523 | 31,125 | 31.2 K to 31.1 K (-0.32 %) |
| Dec 19 2018 | DLB | Dolby Laboratories ... | Baker Giles | SVP, Consumer Enter ... | Option Exercise | A | 64.60 | 25,000 | 1,615,000 | 25,000 | |
| Dec 19 2018 | DLB | Dolby Laboratories ... | Baker Giles | SVP, Consumer Enter ... | Sell | S | 64.52 | 5,932 | 382,745 | 31,225 | 37.2 K to 31.2 K (-15.96 %) |
| Dec 19 2018 | DLB | Dolby Laboratories ... | Baker Giles | SVP, Consumer Enter ... | Sell | S | 65.23 | 100 | 6,523 | 31,125 | 31.2 K to 31.1 K (-0.32 %) |
| Dec 19 2018 | DLB | Dolby Laboratories ... | Baker Giles | SVP, Consumer Enter ... | Grant | A | 0.00 | 12,500 | 0 | 37,157 | 24.7 K to 37.2 K (+50.70 %) |
| Dec 19 2018 | DLB | Dolby Laboratories ... | Baker Giles | SVP, Consumer Enter ... | Sell | S | 64.52 | 5,932 | 382,745 | 31,225 | 37.2 K to 31.2 K (-15.96 %) |
| Dec 19 2018 | DLB | Dolby Laboratories ... | Baker Giles | SVP, Consumer Enter ... | Payment of Exercise | F | 66.17 | 5,937 | 392,851 | 24,657 | 30.6 K to 24.7 K (-19.41 %) |
| Dec 19 2018 | DLB | Dolby Laboratories ... | Baker Giles | SVP, Consumer Enter ... | Grant | A | 0.00 | 12,500 | 0 | 37,157 | 24.7 K to 37.2 K (+50.70 %) |
| Dec 19 2018 | DLB | Dolby Laboratories ... | Baker Giles | SVP, Consumer Enter ... | Payment of Exercise | F | 66.17 | 5,937 | 392,851 | 24,657 | 30.6 K to 24.7 K (-19.41 %) |
| Nov 30 2018 | DLB | Dolby Laboratories ... | Dolby Dagmar | 10% Owner | Option Exercise | C | 0.00 | 1,030,000 | 0 | 7,050,617 | |
| Nov 30 2018 | DLB | Dolby Laboratories ... | Dolby Dagmar | 10% Owner | Gift | G | 0.00 | 1,030,000 | 0 | 0 | 1 M to 0 (-100.00 %) |
| Nov 30 2018 | DLB | Dolby Laboratories ... | Dolby Dagmar | 10% Owner | Buy | C | 0.00 | 1,030,000 | 0 | 1,030,000 | 0 to 1 M |
| Nov 05 2018 | DLB | Dolby Laboratories ... | CHEW LEWIS | EVP & Chief Financi ... | Option Exercise | M | 37.96 | 16,914 | 642,055 | 72,185 | |
| Nov 05 2018 | DLB | Dolby Laboratories ... | CHEW LEWIS | EVP & Chief Financi ... | Option Exercise | M | 37.96 | 18,086 | 686,545 | 89,099 | |
| Nov 05 2018 | DLB | Dolby Laboratories ... | CHEW LEWIS | EVP & Chief Financi ... | Sell | S | 69.32 | 700 | 48,521 | 86,370 | 87.1 K to 86.4 K (-0.80 %) |
| Nov 05 2018 | DLB | Dolby Laboratories ... | CHEW LEWIS | EVP & Chief Financi ... | Sell | S | 68.78 | 16,214 | 1,115,189 | 87,070 | 103.3 K to 87.1 K (-15.70 %) |
| Nov 05 2018 | DLB | Dolby Laboratories ... | CHEW LEWIS | EVP & Chief Financi ... | Buy | M | 37.96 | 16,914 | 642,055 | 103,284 | 86.4 K to 103.3 K (+19.58 %) |
| Nov 05 2018 | DLB | Dolby Laboratories ... | CHEW LEWIS | EVP & Chief Financi ... | Sell | S | 70.03 | 18,086 | 1,266,595 | 86,370 | 104.5 K to 86.4 K (-17.31 %) |
| Nov 05 2018 | DLB | Dolby Laboratories ... | CHEW LEWIS | EVP & Chief Financi ... | Buy | M | 37.96 | 18,086 | 686,545 | 104,456 | 86.4 K to 104.5 K (+20.94 %) |
| Nov 01 2018 | DLB | Dolby Laboratories ... | GOTCHER PETER C | Director | Sell | S | 70.00 | 3,334 | 233,380 | 42,569 | 45.9 K to 42.6 K (-7.26 %) |
| Nov 01 2018 | DLB | Dolby Laboratories ... | GOTCHER PETER C | Director | Sell | S | 70.00 | 3,334 | 233,380 | 42,569 | 45.9 K to 42.6 K (-7.26 %) |
| Sep 06 2018 | DLB | Dolby Laboratories ... | Dolby Dagmar | 10% Owner | Option Exercise | C | 0.00 | 22,642 | 0 | 8,080,617 | |
| Sep 06 2018 | DLB | Dolby Laboratories ... | Dolby Dagmar | 10% Owner | Sell | S | 70.07 | 22,642 | 1,586,486 | 0 | 22.6 K to 0 (-100.00 %) |
| Sep 06 2018 | DLB | Dolby Laboratories ... | Dolby Dagmar | 10% Owner | Buy | C | 0.00 | 22,642 | 0 | 22,642 | 0 to 22.6 K |
| Aug 27 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Option Exercise | M | 28.24 | 30,000 | 847,200 | 95,276 | |
| Aug 27 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 70.00 | 30,000 | 2,100,000 | 32,895 | 62.9 K to 32.9 K (-47.70 %) |
| Aug 27 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Buy | M | 28.24 | 30,000 | 847,200 | 62,895 | 32.9 K to 62.9 K (+91.20 %) |
| Aug 27 2018 | DLB | Dolby Laboratories ... | Baker Giles | SVP, Consumer Enter ... | Option Exercise | M | 37.35 | 5,000 | 186,750 | 43,160 | |
| Aug 27 2018 | DLB | Dolby Laboratories ... | Baker Giles | SVP, Consumer Enter ... | Sell | S | 70.00 | 5,000 | 350,003 | 30,594 | 35.6 K to 30.6 K (-14.05 %) |
| Aug 27 2018 | DLB | Dolby Laboratories ... | Baker Giles | SVP, Consumer Enter ... | Buy | M | 37.35 | 5,000 | 186,750 | 35,594 | 30.6 K to 35.6 K (+16.34 %) |
| Aug 27 2018 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Option Exercise | M | 30.49 | 10,000 | 304,900 | 2,919 | |
| Aug 27 2018 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Sell | S | 70.00 | 10,000 | 700,000 | 48,056 | 58.1 K to 48.1 K (-17.22 %) |
| Aug 27 2018 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Buy | M | 30.49 | 10,000 | 304,900 | 58,056 | 48.1 K to 58.1 K (+20.81 %) |
| Aug 09 2018 | DLB | Dolby Laboratories ... | CHEW LEWIS | EVP & Chief Financi ... | Option Exercise | M | 37.96 | 17,000 | 645,320 | 107,185 | |
| Aug 09 2018 | DLB | Dolby Laboratories ... | CHEW LEWIS | EVP & Chief Financi ... | Sell | S | 65.47 | 17,000 | 1,112,907 | 86,370 | 103.4 K to 86.4 K (-16.45 %) |
| Aug 09 2018 | DLB | Dolby Laboratories ... | CHEW LEWIS | EVP & Chief Financi ... | Buy | M | 37.96 | 17,000 | 645,320 | 103,370 | 86.4 K to 103.4 K (+19.68 %) |
| Aug 03 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 64.97 | 100 | 6,497 | 32,895 | 33 K to 32.9 K (-0.30 %) |
| Aug 03 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 64.47 | 14,900 | 960,631 | 32,995 | 47.9 K to 33 K (-31.11 %) |
| Jul 18 2018 | DLB | Dolby Laboratories ... | Pendleton Todd | SVP, Chief Marketin ... | Option Exercise | A | 62.43 | 125,000 | 7,803,750 | 125,000 | |
| Jul 18 2018 | DLB | Dolby Laboratories ... | Pendleton Todd | SVP, Chief Marketin ... | Grant | A | 0.00 | 17,500 | 0 | 17,500 | 0 to 17.5 K |
| Jul 10 2018 | DLB | Dolby Laboratories ... | Dolby Dagmar | 10% Owner | Option Exercise | C | 0.00 | 27,358 | 0 | 8,103,259 | |
| Jul 10 2018 | DLB | Dolby Laboratories ... | Dolby Dagmar | 10% Owner | Option Exercise | C | 0.00 | 50,000 | 0 | 8,130,617 |